Literature DB >> 22104143

Down-regulation of the human VEGF gene expression by perylene monoimide derivatives.

Thanachai Taka1, Khajohn Joonlasak, Liming Huang, T Randall Lee, Suk-Wah Tam Chang, Wirote Tuntiwechapikul.   

Abstract

The proximal promoter region of the human vascular endothelial growth factor (VEGF) gene contains a guanine-rich strand that can act as a transcriptional silencer by forming an intramolecular G-quadruplex. In this study, we compared two perylene monoimide derivatives, PM1 and PM2, with the well-studied perylene diimide derivative, PIPER, and the well-studied porphyrin derivative, TmPyP(4), with regard to G-quadruplex formation, G-quadruplex binding selectivity, and human VEGF gene silencing in A549 lung cancer cells. The results show that these perylene derivatives can preferentially induce intramolecular G-quadruplex formation from a duplex containing the VEGF G-quadruplex motif in vitro. Incubating A549 lung cancer cells with these perylene derivatives, especially PM2, led to the reduction of both VEGF mRNA and VEGF protein. This study might provide the foundation for the rational design and development of new perylene derivatives as effective anti-angiogenesis agents for cancer therapy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22104143     DOI: 10.1016/j.bmcl.2011.10.089

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  6 in total

1.  Downregulation of the WT1 gene expression via TMPyP4 stabilization of promoter G-quadruplexes in leukemia cells.

Authors:  Saeedeh Ghazaey Zidanloo; Abasalt Hosseinzadeh Colagar; Hossein Ayatollahi; Jahan-Bakhsh Raoof
Journal:  Tumour Biol       Date:  2016-01-27

2.  Hydrosoluble Perylene Monoimide-Based Telomerase Inhibitors with Diminished Cytotoxicity.

Authors:  Pak Thaichana; Ratasark Summart; Pornngarm Dejkriengkraikul; Puttinan Meepowpan; T Randall Lee; Wirote Tuntiwechapikul
Journal:  ACS Omega       Date:  2022-05-05

3.  Evidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesis.

Authors:  Erica Salvati; Pasquale Zizza; Angela Rizzo; Sara Iachettini; Chiara Cingolani; Carmen D'Angelo; Manuela Porru; Antonio Randazzo; Bruno Pagano; Ettore Novellino; Maria Elena Pisanu; Antonella Stoppacciaro; Francesca Spinella; Anna Bagnato; Eric Gilson; Carlo Leonetti; Annamaria Biroccio
Journal:  Nucleic Acids Res       Date:  2013-12-11       Impact factor: 16.971

4.  Targeting glioma stem cells in vivo by a G-quadruplex-stabilizing synthetic macrocyclic hexaoxazole.

Authors:  Takahiro Nakamura; Sachiko Okabe; Haruka Yoshida; Keisuke Iida; Yue Ma; Shogo Sasaki; Takao Yamori; Kazuo Shin-Ya; Ichiro Nakano; Kazuo Nagasawa; Hiroyuki Seimiya
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

Review 5.  Recent Developments in Small-Molecule Ligands of Medicinal Relevance for Harnessing the Anticancer Potential of G-Quadruplexes.

Authors:  Loukiani Savva; Savvas N Georgiades
Journal:  Molecules       Date:  2021-02-05       Impact factor: 4.411

Review 6.  Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer Therapy.

Authors:  Sefan Asamitsu; Shunsuke Obata; Zutao Yu; Toshikazu Bando; Hiroshi Sugiyama
Journal:  Molecules       Date:  2019-01-24       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.